Contemporary Berlin Heart EXCOR Outcomes in North America: Report from the ACTION Registry

Keyphrases

• North America 100%
• Improved Outcomes 100%
• Berlin Heart 100%
• Cardiac Therapy 100%
• EXCOR 60%
• Congenital Heart Disease 20%
• Over 40 10%
• Adverse Events 10%
• Major Bleeding 10%
• Patient Demographics 10%
• Anticoagulation 10%
• Pediatric Heart Failure 10%
• Stroke Incidence 10%
• Ventricular Assist Device 10%
• Heart Disease Diagnosis 10%
• Device Implantation 10%
• Learning Collaborative 10%
• Pump Thrombosis 10%
• Compassionate Use 10%
• Post-approval Changes 10%
• Pediatric Ventricular Assist Device 10%
• Bivalirudin 10%
• Early Implantation 10%
• Anticoagulation Strategy 10%
• Biventricular Assist Device 10%
• INTERMACS Profile 10%
• Heart Failure Programmes 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Congenital Heart Disease 100%
• Cohort Study 50%
• Adverse Event 50%
• Bleeding 50%
• Congestive Heart Failure 50%
• Thrombosis 50%
• Implant 50%
• Bovine Serum Albumin 50%
• Cerebrovascular Accident 50%
• Bivalirudin 50%

Medicine and Dentistry

• Ventricular Assist Device 100%
• Pediatrics 18%
• Anticoagulation 18%
• Persistent Truncus Arteriosus 18%
• Adverse Event 9%
• Apoplexy 9%
• Major Bleeding 9%
• Cohort Analysis 9%
• Implant 9%
• Congestive Heart Failure 9%
• Thrombosis 9%
• Patient Population 9%
• Compassionate Use 9%
• Collaborative Learning 9%
• Bovine Serum Albumin 9%
• Bivalirudin 9%